Clinical trials show small reductions in total cholesterol, LDL cholesterol, and triglycerides alongside their primary metabolic benefits
Article by Amelia Discher RD, LDN Dietitians specializing in GLP-1 Support Nicole Becker RD, LDN Kamryn Brown MS, RD, LDN, CFNIP Evie Copeland MS, RD, LDN, CEDS Julia Curtis MMN, RD McKenzie DeRennaux MA, RD, LDN, CFNIP Amelia Discher RD, LDN Lead Dietitian Amy Gionta MS, RD, LDN, IFNCP Deanna Goldstein MS, RD, LDN Madison Judge RD, LDN McKenna Lewis MS, RD, LDN Holly Nusser MS, RD, LDN Maddie Ring RD, LDN Rachel Shelton RD, LDN Jessica Smosna RD, LDN, CFNIP, CLT Functional Nutrition Director Katie Turchen MS, RD, LDN Chelsea Straight MS, RDN, LDN, CEDS-C, SEP VP of Clinical Operations Start your journey to a Healthier Tomorrow Meet Sara and Sabrina
and both are WADA-prohibited, non-FDA-approved, research-use-only substances
Type 2 Diabetes Focus# Recommendation : Tirzepatide Reason : Tirzepatide has 5 SURPASS T2D trials, FDA approval for diabetes (Mounjaro), and demonstrated superiority over semaglutide in SURPASS-2